To further verify our conclusions, TCGA cohort was explored to investigate the expression of SNHG15 in multiple types of tumor tissues, the abnormal expression of SNHG15 was revealed in cholangiocarcinoma, colon adenocarcinoma, lymphoid neoplasm diffuse large B-cell lymphoma, kidney renal clear cell carcinoma, acute myeloid leukemia (Figure 5A), pancreatic adenocarcinoma, rectum adenocarcinoma, testicular germ cell tumors and thyroid carcinoma and thymoma (Figure 5B). Here, SNHG15 is linked to pancreatic adenocarcinoma.